Cargando…
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy
Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data show an improvement in the quality of life for transgender people who use feminizing hormone therapy. With few transgender-specific data, guidance may be drawn from cisgender (nontransgender) data, with...
Autores principales: | Goldstein, Zil, Khan, Musaub, Reisman, Tamar, Safer, Joshua D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628137/ https://www.ncbi.nlm.nih.gov/pubmed/31372078 http://dx.doi.org/10.2147/JBM.S166780 |
Ejemplares similares
-
Case Report: Induced Lactation in a Transgender Woman
por: Reisman, Tamar, et al.
Publicado: (2018) -
Breast Imaging of Transgender Individuals: A Review
por: Sonnenblick, Emily B., et al.
Publicado: (2018) -
Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals
por: Weinand, Jamie D., et al.
Publicado: (2015) -
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
por: Totaro, Maria, et al.
Publicado: (2021) -
The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)